Article

ASCRS 2020: Eyevance portfolio brimming with product launches

Author(s):

Alex Delaney-Gesing
Conferences|ASCRS

Ophthalmology Times' Sheryl Stevenson speaks with Julie Speed, chief commercial officer of Eyevance Pharmaceuticals, on what's on the agenda for the company's porfolio this year with product launches during the 2020 ASCRS virtual meeting.
 

 

See more ASCRS coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
(Image credit: AdobeStock/Anton Gvozdikov)
April 22nd 2025

When the world went virtual: How ophthalmology’s conferences stayed on track

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment
July 26th 2021

Evaluating safety, efficacy of TP03 for Demodex blepharitis treatment

Oculis releases positive results from Phase 3 OPTIMIZE-1 trial of OCS-01 for treatment of inflammation, pain after cataract surgery
April 8th 2024

Oculis releases positive results from Phase 3 OPTIMIZE-1 trial of OCS-01 for treatment of inflammation, pain after cataract surgery

EyePod
June 17th 2020

ASCRS 2020: Assessing aberration of monofocal toric IOL with enhanced optic recovery, alignment

A novel case of CNGA-3 achromatopsia: Structural changes seen over time
April 7th 2024

A novel case of CNGA-3 achromatopsia: Structural changes seen over time

Measuring biomarkers may Identify patients at risk of retinal vascular progression after cataract surgery
April 7th 2024

Measuring biomarkers may Identify patients at risk of retinal vascular progression after cataract surgery

© 2025 MJH Life Sciences

All rights reserved.